Capricor Therapeutics
Capricor Therapeutics seeks a Network Engineer to design, implement, and support LAN/WAN/WLAN infrastructure across office and laboratory environments. The role involves configuring Cisco devices and Palo Alto firewalls, ensuring network compliance with FDA and SOX requirements, and partnering with Quality teams on validation documentation. This position requires strong troubleshooting skills and the ability to maintain audit-ready documentation in a regulated biotechnology setting.
Headquarters
San Diego, California, United States
Company Size
51-200 employees
Founded
2005
Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a San Diego–based biotechnology company developing cell- and exosome-based therapeutics for muscular and other select diseases. Its lead candidate, deramiocel (CAP‑1002), is an allogeneic cell therapy currently in Phase 3 clinical development for Duchenne muscular dystrophy. Capricor is also advancing exosome technology as a next‑generation platform, engineering exosomes to deliver nucleic acids and proteins to treat or prevent a variety of diseases. The company focuses on translating these platforms into novel therapeutic and preventive products.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Capricor Therapeutics.
Capricor Therapeutics didn’t post a salary, so this is our estimate from similar listings.
3% above the average for this role
Duchenne trial drug from Capricor slows key task decline 83%
23 hours ago